Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization | Zendy

Nam Hee Kim | Zendy; Hong Joo Kim | Zendy; Yong Kyun Cho | Zendy; Hyun Pyo Hong | Zendy; Byung Ik Kim | Zendy

Open Access

Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization

Author(s) -

Nam Hee Kim,

Hong Joo Kim,

Yong Kyun Cho,

Hyun Pyo Hong,

Byung Ik Kim

Publication year - 2019

Publication title -

journal of korean medical science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.743

H-Index - 66

eISSN - 1598-6357

pISSN - 1011-8934

DOI - 10.3346/jkms.2019.34.e208

Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , platelet , embolization , transcatheter arterial chemoembolization , hematology , platelet transfusion , surgery

PSE combined with TACE is effective in inducing and maintaining long-term thrombocytopenia improvement which reduces the need for the platelet transfusion and helps to perform initial and serial TACE, and is well-tolerated in patients with HCC and thrombocytopenia. PSE may be a promising treatment option for HCC patients with severe thrombocytopenia associated with splenomegaly who will undergo TACE.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research